Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...

COVID-19 as a whole is still a major national and international health concern. So far this year, there have been close to 45 ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

So far this year, Australia has recorded close to 45,000 new COVID-19 cases, while around 260 people are currently in ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

Despite milder variants, patients with systemic autoimmune rheumatic diseases remain vulnerable to severe COVID-19 outcomes, ...

Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

Among patients with systemic autoimmune rheumatic diseases, hospitalization due to COVID-19 was more than twice as likely in ...